Title : Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.

Pub. Date : 2020 Apr 1

PMID : 32101030






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice. Glucose nucleotide-binding oligomerization domain containing 2 Mus musculus
2 We found that whole body deletion of RIPK2 prevented the glucose-lowering effects of repeated NOD2 activation that were evident during a glucose tolerance test (GTT) in high-fat diet (HFD)-fed wild-type (WT) mice. Glucose nucleotide-binding oligomerization domain containing 2 Mus musculus
3 We found that whole body deletion of RIPK2 prevented the glucose-lowering effects of repeated NOD2 activation that were evident during a glucose tolerance test (GTT) in high-fat diet (HFD)-fed wild-type (WT) mice. Glucose nucleotide-binding oligomerization domain containing 2 Mus musculus
4 NOD2 activation lowered glucose during a GTT and lowered adipose tissue inflammation in mice with RIPK2 deleted in hematopoietic cells. Glucose nucleotide-binding oligomerization domain containing 2 Mus musculus
5 We conclude that RIPK2 in nonhematopoietic cells mediates the glucose lowering and anti-inflammatory effects of NOD2-activating postbiotics. Glucose nucleotide-binding oligomerization domain containing 2 Mus musculus